Drug Type Monoclonal antibody |
Synonyms ZB 011 |
Target |
Mechanism IGF-1R antagonists(Insulin-like growth factor I receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Graves Ophthalmopathy | Preclinical | CN | 11 May 2022 | |
Graves Ophthalmopathy | Preclinical | CN | 11 May 2022 |